TrialThe Lancet. Oncology2021

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.

Joe Y Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.